[Topical treatment of duodenal and pancreatic fistulas with protease inhibitors].
D000681:Amylases / Q000032:analysis; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D004322:Drainage; D004378:Duodenal Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007412:Intestinal Fistula / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D007419:Intestinal Secretions / Q000032:analysis; D008297:Male; D008722:Methods; D008875:Middle Aged; D010185:Pancreatic Fistula / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D012492:Salts / Q000008:administration & dosage / Q000627:therapeutic use; D014361:Trypsin Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D012492:Salts; D014361:Trypsin Inhibitors; D007611:Aprotinin; D000681:Amylases
Lokalbehandlung von Duodenal- und Pankreasfisteln mit Proteaseninhibitoren.